Objective: To evaluate clinical factors associated with mortality in emergency colectomies performed for Clostridium difficile colitis. Background: The incidence and mortality from C difficile colitis is on the rise. Emergent colectomy performed for C difficile colitis is associated with a high mortality. Methods: The ACS-NSQIP database from 2005 to 2010 was used to study emergently performed open colectomies for a primary diagnosis of C difficile colitis on the International Classification of Diseases, Ninth Revision. Preoperative, intraoperative, and postoperative factors were noted and compared between survivors and nonsurvivors. We performed multivariate stepwise binomial logistic regression analyses to study clinical factors that may be associated with 30-day mortality. Results: The overall mortality for this cohort was 33% (111/335) with a median time to death of 8 days. On average, survivors were discharged on postoperative day 24. On multivariate analysis, those aged 80 years or older were associated with a ninefold increase in the odds of mortality [95% confidence interval (CI): 3.0-13.0]. Other factors associated with increased mortality were preoperative shock (OR = 2.8, 95% CI: 1.6-5.4), preoperative dialysis dependence (OR = 2.3, 95% CI: 1.1-4.8), chronic obstructive pulmonary disease (OR = 3.7, 95% CI: 2.0-7.1), and wound class III (OR = 2.1, 95% CI: 3.0-13). Thrombocytopenia (platelet count < 150 × 10 3 /mm 3 ), coagulopathy (International Normalized Ratio >2.0), and renal insufficiency (blood urea nitrogen > 40 mg/dL) were associated with a higher mortality as well. Conclusions: This is the largest series of colectomies performed for C difficile colitis in the literature. We identified several preoperative clinical risk factors that were associated with increased postoperative mortality. These findings may be useful in selecting appropriate patients for surgical intervention and may help to define a population where surgery may not be beneficial.
The incidence and mortality from C difficile colitis is on the rise. Between 2000 and 2005, there was a 117% rise in the incidence of C difficile-related hospitalization in the United States with an increase in mortality rate from 5.7 per million population in 1999 to 23.7 per million in 2004. 5, 6 It is estimated that 13 out of every 1000 inpatients in the United States are either infected or colonized with C difficile, carrying an associated daily cost of 17.6 million to 51 million dollars to the health care system. 7 Fulminant disease, defined as disease requiring operative intervention or admission to the intensive care unit, develops in 1% to 8% of patients. 8 Multiple investigators have proposed that timely operative intervention may improve survival in patients with fulminant C difficile colitis (FCDC). However, the prognosis of these patients who progress to FCDC remains grave, with postoperative mortality rates ranging from 24% to 80%. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Studies of FCDC requiring colectomies have been mostly limited to small and medium retrospective series. Currently, the largest study in the literature is composed of 130 patients who underwent colectomy during an outbreak of a virulent strain of C difficile. 20 It is important to identify factors associated with the development of FCDC and postoperative mortality to select patients who may benefit from timely surgical intervention. Therefore, we utilized the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP) Participant User File (PUF) database to study preoperative, intraoperative, and postoperative factors that may be associated with mortality after emergency colectomy performed for the treatment of C difficile colitis.
METHODS
This review of the ACS-NSQIP PUF database was performed with approval from our institutional review board and the data use agreement of the ACS. The ACS-NSQIP is the first nationally validated, risk-adjusted outcomes-based program designed to measure and improve the quality of surgical care. The program collects data on 136 pre-, intra-, and postoperative clinical variables. In addition, 30-day postoperative mortality and morbidity data is collected in the database. Currently, there are more than 200 hospitals that participate in this program. 21 We queried the ACS-NSQIP PUF database from 2005 to 2010 for open colectomies using Current Procedural Terminology (CPT) codes: 44140-1, 44143-6, 44150-1, 44155-7, and 44160. We then selected for emergent cases performed for postoperative diagnosis of C difficile colitis using the International Classification of Diseases, Ninth Revision (ICD-9) code-008.45. Cases with secondary CPT codes for other procedures were excluded from this study (Table 1) . ACS-NSQIP postoperative diagnoses are noted from the operative note and/or pathology report by trained surgical clinical nurse reviewers. All hospitals are subject to audit by ACS-NSQIP and any hospital's data that are inconsistent by 5% or more are not included in the PUF database. The average disagreement rate by the audit process is 2.5% for all assessed program variables.
Clinically relevant pre-, intra-, and postoperative events were noted and reviewed. All clinical factors in the ACS-NSQIP PUF database are defined in the user guide. 22 Categorical variables were compared between the survivors and nonsurvivors by χ 2 test and continuous variables with the Student t test. In addition, we performed a univariate binomial logistic regression for all factors studied. We then performed a multivariate stepwise logistic regression to generate odds ratios (ORs) for factors associated with mortality. Survival analysis was performed for factors found to be significant on multivariate analysis by constructing life-tables. All tests were 2-tailed and P ≤ 0.05 were considered significant. All statistical analyses were performed on SPSS for Windows version 17 (SPSS Inc, Chicago, IL).
RESULTS
Our selection criteria yielded 335 cases. Overall, 25% of the cases were coded as partial colectomies, whereas 75% of the cases were coded as total colectomies. There was no significant difference in the operation type between survivors and nonsurvivors (P = 0.502; Table 1 ).
There were 111 postoperative deaths yielding a 30-day mortality rate of 33%. The average time to death after operation was 9 days (median = 8 days). Forty-five (41%) of all deaths occurred between postoperative days 0 and 5 ( Fig. 1) . For survivors, the average time to discharge was 24 days (median = 18 days).
The demographics and the comorbidities of survivors and nonsurvivors are shown in Table 2 . On average, patients who survived For abbreviations, see Table 2 footnotes. All conditions are defined by the NSQIP data guideline; Significant clinical factors and ORs are bolded and P values are denoted by * .
were younger, had a lower American Society of Anesthesiologist Classification (ASA class) score, and were more functionally independent prior to the operation compared with nonsurvivors. In addition, a higher proportion of nonsurvivors had cardiac, pulmonary, endocrine, and renal comorbidities compared with survivors. Those who did not survive to discharge experienced more preoperative adverse events including shock, respiratory failure resulting in ventilator dependence, and acute renal failure. On univariate analysis, age 80 years or older, ASA class IV and V, dependent functional status, and preoperative adverse events including, shock, ventilator dependence, and renal failure were all significantly related to mortality. In addition, history of congestive heart failure, cardiac surgery, dyspnea at rest, severe chronic obstructive pulmonary disease (COPD) as defined by NSQIP, preoperative dialysis dependence, and chronic steroid usage were also associated with higher mortality (Table 3) . A higher proportion of patients who received chemotherapy before the development of C difficile colitis survived compared with those who did not. On multivariate analysis, however, the only preoperative factors predictive of mortality were age 80 years or older [OR = 9.0, 95% confidence interval (CI): 3.0-13], preoperative shock (OR = 2.8, 95% CI: 1.6-5.4), COPD (OR = 3.7, 95% CI: 2.0-7.1), and dialysis dependence (OR = 2.3, 95% CI: 1.1-4.8).
We also assessed preoperative laboratory values available in the ACS-NSQIP PUF database. The comparison of laboratory values between survivors and nonsurvivors are shown in Table 4 . On univariate analysis, multiple laboratory values, including white blood cell (WBC) count of 50,000/μL or more, were associated with mortality (Table 5 ). However, on multivariate analysis, the only factors significantly associated with mortality were blood urea nitrogen more than Table 6 . Survivors on average had a longer operation, but operation type, resident participation, and intraoperative transfusions were similar between the 2 groups. Analyses of postoperative events revealed that wound class III--defined as a contaminated wound with a major break in operative technique, gross spillage from the gastrointestinal tract, or incision encountering acute nonpurulent inflammation 23 -and postoperative cardiac arrests were both significantly associated with mortality on both univariate and multivariate analyses (Tables 7  and 8) .
We also performed survival analysis on all preoperative factors found to be significant on our multivariate analysis. Patient aged 80 years or older, preoperative dialysis dependence, preoperative shock, and severe COPD as defined by NSQIP were associated with significantly higher mortality ( Figs. 2A-D) .
DISCUSSION
Epidemiologic studies show that the incidence and the mortality due to C difficile colitis are rising. 5, 6 Although the majority of the patients respond to therapy with metronidazole, vancomycin, or both, those who are refractory to medical treatment are at a risk of developing FCDC. 8 Although colectomy is often viewed as a last resort treatment in the treatment of FCDC, there is some evidence to suggest that a subset of patients may benefit from earlier operative intervention. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] However, attempts to identify these patients have been difficult due to the small number of cases studied in most series.
Many investigators have sought to identify factors associated with the development of FCDC. Some of the clinical factors implicated in the progression to fulminant disease include patient age, high lactate level, leukocytosis, previous operation within 30 days, and a history of inflammatory bowel disease and its treatment. 14, 24, 25 More recently, North American PGFE type (BI/NAP1) isolates of C difficile and gene mutation resulting in resistance to fluoroquinolones have also been implicated. 26, 27 Prior studies, although limited by a small numbers of cases, have implicated high ASA class score, advanced age, hypoalbuminemia, high lactate level, leukocytosis, organ failure, mental status changes, and shock as predictors of mortality. 10, 11, 17, [28] [29] [30] In our multivariate analysis, we identified advanced age, preoperative shock, preoperative dialysis dependence, COPD, postoperative cardiac arrest, and wound classification III as risk factors predicting mortality. Although preoperative factors such as patient age and COPD are not modifiable, timely operative intervention to avoid preoperative shock and dialysis may be important in lowering the risk of mortality after colectomy. Evaluation of laboratory values recorded in the NSQIP database found thrombocytopenia, coagulopathy, and renal insufficiency as factors associated with mortality on our multivariate analysis. Derangement of these laboratory values may be a reflection of underlying sepsis or organ dysfunction. This underscores the need for intervention before multiorgan dysfunction develops.
Although lactate and the WBC are commonly used to guide the therapy of C difficile colitis, we were limited in our ability to evaluate these 2 parameters in our study. The average WBC for our survivors and nonsurvivors was greater than 25,000/μL and similar in both groups. Although WBC equal to 50,000/μL was associated with mortality on our univariate analysis, it was not significant on our multivariate analysis. Furthermore, the highest possible recording of WBC in the NSQIP database is 50,000/μL. This limits our ability to perform meaningful statistical analysis for patients with very high WBC counts. Finally, ACS-NSQIP PUF database does not record lactate level.
COPD is a risk factor, which has not been previously implicated in mortality in the study of FCDC. The diminished respiratory reserves of patients who have COPD may predispose them to an increased risk of pulmonary complications that may in turn result in higher mortality. The 3.7-fold increase in mortality seen in this study is significant and stresses the importance of considering this risk factor preoperatively.
In our analyses of intraoperative and postoperative events related to mortality, wound classification III and cardiac arrest requiring cardiopulmonary resuscitation were associated with postoperative mortality. Contaminated wound may indicate the progression of disease, which has resulted in gross-spillage into the abdomen.
Cardiac arrest is an obvious risk factor for postoperative mortality; however, we found that history of cardiac disease or cardiac interventions were not associated with mortality on our multivariate analysis. This suggests that patients with incidental cardiac history may not need to be disqualified as operative candidates.
The 33% mortality rate in this series is within the range of previously reported mortality. However, our study shows that even those who survive have a prolonged length of stay in the hospital. The median time to hospital discharge in our series was 24 days, which underscores the burden that FCDC can have on the health care system.
Our study has several limitations. The main limitation of our study is that this is an observational study based on retrieval of data from a database. Although the data acquisition method of the NSQIP database has been validated, we were only able to study factors included in the NSQIP database. Patient selection is dependent on the assignment of a CPT code and postoperative diagnoses, which could potentially miss some cases. In addition, although the NSQIP database derives data from more than 200 hospitals, the data may not be an accurate representation of all cases performed in the United States.
An additional limitation of our study is the possible coding variability associated with subtotal colectomies. Most surgeons have been trained to perform a subtotal colectomy for fulminant C difficile colitis. However, no specific CPT code exists for a subtotal colectomy. Depending on the amount of rectal stump that is left, a subtotal colectomy may be coded as a partial colectomy, even when in fact, the majority of the colon has been removed. Furthermore, a diseased appearing rectum or inflammation at the rectosigmoid junction may result in removal of part of the rectum. Nevertheless, we do not think this detracts from our study given that no certain CPT codes or operation type were associated with mortality in our study.
It is important to identify clinical factors associated with mortality to develop a treatment strategy for FCDC. Despite some limitations, to our knowledge this is the largest study evaluating colectomies performed for C difficile colitis. Use of a high-quality national database has allowed us to identify factors associated with postoperative mortality in the treatment of FCDC.
CONCLUSIONS
Advanced patient age, preoperative shock, preoperative dialysis dependence, COPD, and wound class III were all associated with postoperative mortality on our multivariate analysis. In addition, thrombocytopenia, coagulopathy, and renal insufficiency detected by laboratory values were associated with mortality as well. Patients with the aforementioned risk factors are at high risk for mortality even after undergoing colectomy for C difficile colitis and should be counseled carefully. Identification of the risk factors associated with mortality may help us to select patients who are most likely to benefit from surgical intervention. Ideally, operative intervention should be offered to patients before they develop multiorgan failure.
